These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11567932)

  • 1. Therapeutic choices in the locomotor management of the child with cerebral palsy--more luck than judgement?
    Patrick JH; Roberts AP; Cole GF
    Arch Dis Child; 2001 Oct; 85(4):275-9. PubMed ID: 11567932
    [No Abstract]   [Full Text] [Related]  

  • 2. Spasticity in children and young people with non-progressive brain disorders: summary of NICE guidance.
    Mugglestone MA; Eunson P; Murphy MS;
    BMJ; 2012 Jul; 345():e4845. PubMed ID: 22836108
    [No Abstract]   [Full Text] [Related]  

  • 3. Potentiation of botulinum toxin type A with oral anti-spasticity medications in the management of focal spasticity.
    Dai A
    J Rehabil Med; 2007 Mar; 39(2):189; author reply 189. PubMed ID: 17351705
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic interventions for tone abnormalities in cerebral palsy.
    Tilton AH
    NeuroRx; 2006 Apr; 3(2):217-24. PubMed ID: 16554259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of spasticity in children with cerebral palsy.
    Tilton A
    Semin Pediatr Neurol; 2009 Jun; 16(2):82-9. PubMed ID: 19501336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of kinematics parameters of pelvis during walking under the influence of means facilitates treatment of cerebral palsied children.
    Czupryna K; Nowotny J
    Ortop Traumatol Rehabil; 2012; 14(5):453-65. PubMed ID: 23208937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rehabilitation of spasticity and related problems in childhood cerebral palsy.
    Flett PJ
    J Paediatr Child Health; 2003; 39(1):6-14. PubMed ID: 12542805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle synergies demonstrate only minimal changes after treatment in cerebral palsy.
    Shuman BR; Goudriaan M; Desloovere K; Schwartz MH; Steele KM
    J Neuroeng Rehabil; 2019 Mar; 16(1):46. PubMed ID: 30925882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of cerebral palsy: What we know, what we don't know.
    Goldstein M
    J Pediatr; 2004 Aug; 145(2 Suppl):S42-6. PubMed ID: 15292887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New therapeutic methods for spasticity and dystonia in children with cerebral palsy require multidisciplinary team work. Comprehensive approach yields good results].
    Westbom L; Hägglund G; Lundkvist A; Nordmark E; Strömblad LG
    Lakartidningen; 2003 Jan; 100(3):125-30. PubMed ID: 12596478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A injections for treatment of spastic equinus in cerebral palsy: a secondary analysis of factors predictive of favorable response.
    Sätilä H; Huhtala H
    Am J Phys Med Rehabil; 2010 Nov; 89(11):865-72. PubMed ID: 20736816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intrathecal baclofen, botulinum toxin type A and a rehabilitation programme on locomotor function after spinal cord injury: a case report.
    Santamato A; Panza F; Ranieri M; Amoruso MT; Amoruso L; Frisardi V; Solfrizzi V; Fiore P
    J Rehabil Med; 2010 Oct; 42(9):891-4. PubMed ID: 20878052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cerebral palsy therapy].
    Papazian O; Alfonso I
    Rev Neurol; 1997 May; 25(141):728-39. PubMed ID: 9206600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Casting Protocols Following BoNT-A Injections to Treat Spastic Hypertonia of the Triceps Surae in Children with Cerebral Palsy and Equinus Gait: A Randomized Controlled Trial.
    Kelly B; MacKay-Lyons M; Berryman S; Hyndman J; Wood E
    Phys Occup Ther Pediatr; 2019; 39(1):77-93. PubMed ID: 29771161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Botulinum toxin A in the treatment of infantile cerebral palsy. Taking into account multilevel, integrated treatment].
    Molenaers G; Desloovere K; De Cat J
    Orthopade; 2004 Oct; 33(10):1119-28. PubMed ID: 15278274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Spasticity management and progress in ambulatory cerebral palsy].
    Filipetti P; Caldas C; Delpierre Y
    Arch Pediatr; 2006 Jun; 13(6):614-5. PubMed ID: 16697586
    [No Abstract]   [Full Text] [Related]  

  • 17. [Management of spasticity in children with cerebral palsy].
    Matthews DJ; Balaban B
    Acta Orthop Traumatol Turc; 2009; 43(2):81-6. PubMed ID: 19448346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin a injection into calf muscles for treatment of spastic equinus in cerebral palsy: a controlled trial comparing sonography and electric stimulation-guided injection techniques: a preliminary report.
    Kwon JY; Hwang JH; Kim JS
    Am J Phys Med Rehabil; 2010 Apr; 89(4):279-86. PubMed ID: 20068435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Botox in combined treatment of cerebral palsy in children].
    Kalinina LV; Sologubov EG; Luzinovich VM; Dutikova EM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(12):60-3. PubMed ID: 11195541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronox versus BOTOX for spastic equinus gait in children with cerebral palsy: a randomized, double-blinded, controlled multicentre clinical trial.
    Kim K; Shin HI; Kwon BS; Kim SJ; Jung IY; Bang MS
    Dev Med Child Neurol; 2011 Mar; 53(3):239-44. PubMed ID: 21087238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.